Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
The Journal of Infectious Diseases|March 30, 2012
A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosisGuoliang Zhang, Boping Zhou, Wenfei Wang, et al.
Microbiological Research|January 3, 2025
Assessing the risk of TB progression: Advances in blood-based biomarker researchZhaodong Li, Yunlong Hu, Fa Zou, et al.
Tuberculosis (Edinburgh, Scotland)|March 9, 2026
Transcriptomic signatures predict severe linezolid-induced peripheral neuropathy and reveal pre-treatment immune and antioxidant dysregulationChenyan Shi, Peize Zhang, Junfeng Zhen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 19, 2020
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreakDachuan Lin, Lei Liu, Mingxia Zhang, et al.
Journal of Leukocyte Biology|September 17, 2021
Flunarizine suppresses Mycobacterium tuberculosis growth via calmodulin-dependent phagosome maturationSiwei Mo, Xiaoqian Liu, Kehong Zhang, et al.
Science China. Life Sciences|April 19, 2020
Distinct lung microbial community states in patients with pulmonary tuberculosisYongfeng Hu, Ying Kang, Xi Liu, et al.
Virology Journal|July 5, 2025
UMPlex™: a targeted next-generation sequencing primer design workflowDachuan Lin, Xiaomin Zhang, Dan Wang, et al.
Clinical Immunology (Orlando, Fla.)|January 20, 2007
CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active diseaseXinchun Chen, Boping Zhou, Meizhong Li, et al.
American Journal of Respiratory Cell and Molecular Biology|May 9, 2014
Growth factor receptor bound protein 2-associated binder 2, a scaffolding adaptor protein, negatively regulates host immunity against tuberculosisShizong Hu, Yan Zhang, Yang Yu, et al.
Tuberculosis (Edinburgh, Scotland)|February 26, 2014
Anti-tuberculosis treatment enhances the production of IL-22 through reducing the frequencies of regulatory B cellMingxia Zhang, Gucheng Zeng, Qianting Yang, et al.
Pageof 19